Form 10-Q Sana Biotechnology, Inc. For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Sana Biotechnology (SANA) PT Raised to $15 at Citi, Opens Positive Catalyst Watch
August 9, 2024 5:01 AM EDTCiti analyst Samantha Semenkow raised the price target on Sana Biotechnology (NASDAQ: SANA) to $15.00 (from $8.00) while maintaining a Buy rating.
The analyst comments "Sana disclosed they have enrolled multiple T1D patients into the IST being conducted in Uppsala, Sweden. The... More
